Editas Medicine ↗
Biotechnology: Biological Products (No Diagnostic Substances) company
Key Metrics of Editas Medicine
Revenue$78.1M▲ 296.3% YoYFY 2023
Operating income−$169M▲ 25.1% YoY
Net profit−$153M▲ 30.5% YoY
Shareholders' equity$349M
Market cap$453MEDIT · $2.95
Competitors10identified
About Editas Medicine
Sectors
Company details
- Website
- editasmedicine.com
- Founded
- 2016
- Listed
- Nasdaq: EDIT (since 2016)
Operational Areas of Editas Medicine
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameEditas Medicine Inc.
TickerEDIT
ExchangeNasdaq
CountryUnited States
SEC CIK0001650664
Listed since2016
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Websitehttps://www.editasmedicine.com
US market & SEC filings
EDIT · Nasdaq · SEC CIK 0001650664
Last price · 30 Oct 2026
$2.95
+13.46%
Market cap$453M
P/E—On FY 2023 diluted EPS
Volume4,430,137
SectorHealth CareBiotechnology: Biological Products (No Diagnostic Substances)
Country · IPOUnited StatesListed 2016
EDIT share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeCambridge
GSTIN—
Email—
Websitehttps://www.editasmedicine.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Editas Medicine
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
pharmaceutical industry
Filings
No filings on record yet.